Short-Term Trade Idea: Max Healthcare Forms Bullish Reversal, Analyst Recommends Buying On Dips

The analyst sees short-term upside to ₹1,200 if ₹1,135 support holds.
Retail Sentiment on the stock inched down to ‘neutral’| Source: Pixabay
Retail Sentiment on the stock inched down to ‘neutral’| Source: Pixabay
Profile Image
Preeti Ayyathurai·Stocktwits
Updated Mar 05, 2026   |   2:29 PM EST
Share
·
Add us onAdd us on Google
Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...

Max Healthcare shares surged over 6% on Monday after the Central Government Health Services (CGHS) announced a revision of rates for nearly 2,000 medical procedures under the scheme. The new rates will take effect on October 13, 2025. 

SEBI-registered analyst Deepak Pal noted this move boosts realization outlook for hospital chains handling CGHS cases, such as Max Healthcare. 

Max Healthcare formed a wide-range bullish reversal candle on Monday after opening at ₹1,107.90, making an intraday low of ₹1,101.80 and a high of ₹1,148.10 before closing at ₹1,143.20, which signals strong intraday buying and short-covering. Pal said that the stock was now holding above the 14-day Exponential Moving Average (EMA) and the ₹1,135 horizontal support, with the RSI rebounding from below 50 toward the mid-50s and the daily MACD histogram flattening (still negative), suggesting a short-term mean reversion attempt rather than a confirmed trend reversal. 

Read Next
Loading...
Loading...

Advertisement|Remove ads.

He identified support at ₹1,135 (14-day EMA) and ₹1,120 (stopwatch support), with immediate resistance at ₹1,190–₹1,200 and a higher resistance cluster near the 50 DMA around ₹1,240–1,260. 

What Should Investors Do Now?

For a short-term trade (speculative), Pal suggested buying on dips at ₹1,135–1,140 with a stop loss of ₹1,120 and target prices of ₹1,190 (first) and ₹1,200 (stretch). Scale out 50% at the first target. 

Advertisement|Remove ads.

For an intraday setup, he advised traders to go long above the intraday high (₹1,148) on momentum with a tight trailing stop below the 14-day EMA. 

For positional traders and investors, Pal advised a staggered accumulation (SIP style) or waiting for consolidation above ₹1,200 to reduce valuation risk. 

Technical Outlook

Advertisement|Remove ads.

In the short term, Pal is constructive on Max Health if ₹1,135 holds, and expects the stock to test ₹1,190–₹1,200 in a follow-through scenario. In the medium-term scenario, he remains neutral to cautious as the stock traded below longer moving averages, and needed a higher high and higher low confirmation. 

Over the long term, he noted Max’s positive business case, but feels that technical confirmation is required. He advised traders to watch for a monthly close relative to the 50 and 100-month smoothing for a structural turn. 

Triggers To Watch

Advertisement|Remove ads.

Monitor the following quarterly updates and management commentary on occupancy, ARPOB, and guidance. Pal added that any upside surprise can trigger strong moves, but a miss may cause a sharp re-rating because of current high multiples. Additionally, policy updates on insurance reimbursements, NABH/NABL accreditations, and major tie-ups with insurers or govt schemes, which can affect volumes and collections, would be other catalysts to watch.

What Is The Retail Mood?

Advertisement|Remove ads.

Data on Stocktwits shows that retail sentiment has been ‘bullish’ for a week on this counter.

Screenshot 2025-10-07 085621.png
Max Health sentiment and message volume on Oct 7 as of 9:00 am IST. | source: Stocktwits

Max Healthcare shares are flat year-to-date (YTD).

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Advertisement|Remove ads.

Comments
Share your thoughts...

Comments posted here will also appear on symbol pages.

Follow on Google News
Read about our editorial guidelines and ethics policy

Advertisement|Remove ads.